FUJIFILM ANNOUNCES FIRST RECIPIENTS OF THE FUJIFILM FELLOWSHIP TO SUPPORT TRANSLATIONAL MEDICINE
Established through a $1,000,000 gift from Fujifilm to Harvard Medical School, the program will advance education and research in the field of translational medicine.
Cambridge, Mass., July 29, 2019 – FUJIFILM Holdings America Corporation (Fujifilm), today announced the first-ever recipients of the Fujifilm Fellowship at Harvard Medical School (HMS).
“We are proud to announce the inaugural group of Fujifilm Fellows who are passionate about providing solutions to the evolving needs of our society,” said Yutaka Yamaguchi, General Manager of the new Fujifilm Life Science Strategic Business Office. “Fujifilm is committed to providing resources to advance the next generation of healthcare leaders with the goal of bringing new treatment and diagnosis options to market to help change lives.”
The inaugural group of Fujifilm Fellowship recipients includes Michael Mazzola, Reina Iwase, and Martha Ordonez.
“We view the establishment of the Fujifilm Fellowship as a partnership of true innovators,” said Bruce E. Novich, Sc.D., Division President, Corporate New Business Development Division, FUJIFILM Holdings America Corporation. “Fujifilm has always had the mission to contribute to the betterment of all global citizens and of human society at large. We share this mission with Harvard Medical School.”
Established through a gift of $1,000,000, the Fujifilm Fellowship Fund was designed by Fujifilm and HMS to advance translational medical research by investing in future therapeutics innovators. The selected beneficiaries who have been admitted to Harvard Medical School’s Therapeutics Graduate Program will be provided with financial assistance to pursue their education and research in therapeutic innovation. The program is expected to support about six students for the next two years.
For more information, please visit https://www.fujifilmhealthcare.com/life-sciences-strategy.
FUJIFILM Holdings America Corporation is the regional headquarters for the Americas. It is comprised of 21 affiliate companies across North and Latin America. The company manufactures, markets and provides service for a broad spectrum of industries including photographic, medical imaging and informatics, pharmaceutical, regenerative medicine, and biopharmaceutical contract manufacturing. Industrial segments include data storage, electronic materials, chemical, industrial testing products, and graphic arts products and services. For more information, please visit: www.fujifilmusa.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.